Seeking Alpha

Catalyst Biosciences Sends Letter to Stockholders

Reiterates the Board’s Commitment to Expeditiously Distributing All of the Company’s Available Cash to Stockholders, Net of Liabilities and Obligations Warns Stockholders that JDS1 May Have Ulterior ...
Business Insider

Catalyst Biosciences to Present at the Stifel Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer of Catalyst ...
Business Insider

Catalyst Biosciences Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other ...
CNN

Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis

SOUTH SAN FRANCISCO, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced two presentations at the upcoming International Society on Thrombosis and ...
Winston-Salem Journal

Catalyst Biosciences' share price takes major hit after halting clinical trial

An announcement by Catalyst Biosciences Inc. that it has halted an early stage trial for its hemophilia B treatment sent the share price of the lightly traded stock plunging 63.9 percent Monday. The ...
CNN

Catalyst Biosciences Receives Patent in the European Union for Its Factor IX Portfolio

SOUTH SAN FRANCISCO, Calif., April 28, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company developing novel subcutaneous (SQ) therapies for hemophilia and ...
Reuters

Catalyst Biosciences secures all rights to manufacturing process for Marzeptacog Alfa from Wyeth LLC, a wholly-owned subsidiary of Pfizer

* Catalyst Biosciences Inc - has secured all rights to manufacturing process for Marzeptacog Alfa from Wyeth LLC, a wholly-owned subsidiary of Pfizer * Catalyst Biosciences Inc - has signed a drug ...
The Business Journals

Shareholders approve merger of Bay Area biopharma Catalyst Biosciences

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The merger aims to right the ship after a the company ...